119621796	119621796	CD	B-NP	O
|	|	NNP	I-NP	O
WH	WH	NNP	I-NP	O
|	|	VBD	B-VP	O
21927445	21927445	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
733455	733455	CD	B-NP	O
|	|	CC	I-NP	O
7/10/2001	7/10/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/18/2001	2/18/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/21/2001	9/21/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
TINELLI	TINELLI	NN	B-NP	O
,	,	,	O	O
ZACHARY	ZACHARY	NN	B-NP	O
197-18-63-9	197-18-63-9	CD	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/26/01	7/26/01	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SHELLHAAS	SHELLHAAS	NNP	B-NP	O
,	,	,	O	O
FIDEL	FIDEL	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
XANAX	XANAX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALPRAZOLAM	ALPRAZOLAM	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sedation	sedation	NN	B-NP	O
MECLIZINE	MECLIZINE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MECLIZINE	MECLIZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
25	25	CD	I-NP	B-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
vertigo	vertigo	NN	I-NP	I-protein
NORTRIPTYLINE	NORTRIPTYLINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
HS	HS	NN	I-NP	I-protein
TRAZODONE	TRAZODONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
HS	HS	NNP	I-NP	I-protein
VERAPAMIL	VERAPAMIL	NNP	I-NP	I-protein
SUSTAINED	SUSTAINED	VBD	B-VP	I-protein
RELEAS	RELEAS	NNP	B-NP	I-protein
120	120	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
qAM	qAM	NN	I-NP	O
;	;	:	O	O
300	300	CD	B-NP	O
MG	MG	NN	I-NP	O
qNoon	qNoon	NN	I-NP	O
;	;	:	O	O
600	600	CD	B-NP	O
MG	MG	NN	I-NP	O
qPM	qPM	NN	I-NP	O
PO	PO	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
qAM	qAM	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
qNoon	qNoon	NN	I-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
qPM	qPM	NN	I-NP	O
SEROQUEL	SEROQUEL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QUETIAPINE	QUETIAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
ready	ready	JJ	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Mckinley	Mckinley	NNP	B-NP	O
Choma	Choma	NNP	I-NP	O
at	at	IN	B-PP	O
Is	Is	NNP	B-NP	O
-	-	HYPH	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
within	within	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
234-865-1925	234-865-1925	CD	B-NP	O
within	within	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Hemoptysis	Hemoptysis	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PE	PE	NNP	B-NP	O
,	,	,	O	O
INR	INR	NNP	B-NP	O
7.5	7.5	CD	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
h/o	h/o	NN	B-NP	O
drug	drug	NN	I-NP	O
overdose	overdose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
drug	drug	NN	I-NP	O
overdose	overdose	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
PE	PE	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
embolism	embolism	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
gerd	gerd	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
38	38	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
recent	recent	JJ	I-NP	O
PE	PE	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
6/22	6/22	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
p/w	p/w	NN	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
,	,	,	I-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
supratherapeutic	supratherapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
7.2	7.2	CD	B-NP	O
,	,	,	O	O
post	post	IN	B-PP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
abrasions	abrasion	NNS	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
altho	altho	NN	B-NP	O
'	'	POS	B-NP	O
pt	pt	NN	I-NP	O
reports	report	VBZ	B-VP	O
recent	recent	JJ	B-NP	O
hematochezia	hematochezia	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
c/o	c/o	JJ	I-NP	O
GERD	GERD	NNP	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
nl	nl	NN	I-NP	O
;	;	:	O	O
EKG	EKG	NN	B-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
,	,	,	O	O
NSR	NSR	NN	B-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sttw	sttw	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

DDimer	DDimer	NN	B-NP	O
nl	nl	NN	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
r/o	r/o	NN	B-NP	B-protein
mi	mi	NNS	I-NP	I-protein
-LRB-	-LRB-	SYM	O	I-protein
6/22	6/22	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	B-ADJP	I-protein
although	although	IN	B-SBAR	O
CRFs	CRF	NNS	B-NP	B-protein
only	only	RB	B-NP	O
cigs	cig	NNS	I-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
cocaine	cocaine	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
6/22	6/22	CD	I-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
wma	wma	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
on	on	IN	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
for	for	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
PPD	PPD	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
without	without	IN	B-PP	O
cough/sputum/not	cough/sputum/not	NN	B-NP	O
systemically	systemically	RB	B-ADVP	O
ill	ill	RB	I-ADVP	O
.	.	.	O	O

Tx	Tx	NN	B-NP	O
'd	'd	VBD	B-VP	O
with	with	IN	B-PP	O
Vit	Vit	NNP	B-NP	B-protein
K	K	NNP	I-NP	I-protein
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
trial	trial	NN	I-NP	O
initiated	initiate	VBD	B-VP	O
,	,	,	O	O
domestic	domestic	JJ	B-NP	O
violence	violence	NN	I-NP	O
social	social	JJ	I-NP	O
work	work	NN	I-NP	O
consulted	consult	VBD	B-VP	O
.	.	.	O	O

Tox	Tox	NN	B-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
depression	depression	NN	I-NP	O
w/hx	w/hx	NN	I-NP	O
si/sa/drug	si/sa/drug	NN	I-NP	O
overdose	overdose	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
psych	psych	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

D/c	D/c	NN	B-NP	O
'd	'd	MD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
jail	jail	NN	B-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
INR	INR	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
on	on	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
current	current	JJ	B-NP	O
meds	med	NNS	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
ds	d	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
given	give	VBN	I-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
cocaine	cocaine	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

other	other	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
lung	lung	NN	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

Contact	Contact	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
further	further	RBR	B-NP	O
bleeding	bleeding	JJ	I-NP	O
,	,	,	O	O
feel	feel	VBP	B-VP	O
faint	faint	JJ	B-NP	O
or	or	CC	I-NP	O
lose	lose	JJ	I-NP	O
consciousness	consciousness	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
have	have	VBP	B-VP	O
worsened	worsen	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
are	be	VBP	B-VP	O
starting	start	VBG	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
for	for	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	B-protein
reflux	reflux	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
prilosec	prilosec	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
decrease	decrease	VB	I-VP	O
your	your	PRP$	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Kendster	Kendster	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
County	County	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
maintained	maintain	VBN	I-VP	O
between	between	IN	B-PP	O
2-3	2-3	CD	B-NP	O
as	as	IN	B-PP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
5	5	CD	B-NP	O
times	time	NNS	I-NP	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
go	go	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
once	once	VB	I-VP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Restart	Restart	VB	B-VP	O
coumadin	coumadin	NN	B-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
and	and	CC	O	O
start	start	VB	B-VP	O
monitoring	monitor	VBG	I-VP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
stably	stably	RB	B-ADVP	O
between	between	IN	B-PP	O
2-3	2-3	CD	B-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
consecutive	consecutive	JJ	I-NP	O
draws	draw	NNS	I-NP	O
.	.	.	O	O

Adjust	Adjust	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
Follow	Follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
included	include	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MARRERO	MARRERO	NNP	B-NP	O
,	,	,	O	O
BUSTER	BUSTER	NNP	B-NP	O
WAYNE	WAYNE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FI22	FI22	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/26/01	7/26/01	CD	I-NP	O
@	@	NN	I-NP	O
07	07	CD	I-NP	O
:	:	:	O	O
35	35	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

